Dnaja3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
DNAJA3, also known as TID1 (Tumorous Imitator of DnaJ 1), is a mitochondrial DnaJ/Hsp40 co-chaperone involved in mitochondrial protein quality control, apoptosis regulation, and stress responses. It plays important roles in neuronal survival and has been implicated in neurodegenerative diseases.
DNAJA3 encodes a protein primarily localized to mitochondria that functions as a co-chaperone for mitochondrial Hsp70 (mtHsp70, also known as GRP75/mortalin). It is involved in protein import into mitochondria, folding, and the management of misfolded proteins. DNAJA3 also interacts with key proteins involved in apoptosis and cell survival.
| Attribute |
Value |
| Gene Symbol |
DNAJA3 |
| Chromosome |
16p13.3 |
| Protein Size |
480 amino acids |
| Molecular Weight |
~52 kDa |
| Expression |
High in heart, muscle, brain |
- Co-chaperone for mitochondrial Hsp70
- Assists protein import via TIM complex
- Facilitates protein folding in mitochondria
- Helps manage misfolded proteins
- Interacts with Bcl-2 family proteins
- Modulates caspase activation
- Protects against oxidative stress
- Influences p53 function
- Modulates NF-κB signaling
- Affects JNK pathway
- Regulates interferon responses
- Mitochondria-nucleus signaling
- DNAJA3 interacts with Parkin (PRKN)
- Modulates PINK1/Parkin mitophagy
- Mitochondrial dysfunction in PD models
- Genetic variants may affect PD risk
- Mitochondrial dysfunction in AD
- Aβ affects mitochondrial protein import
- DNAJA3 levels altered in AD brains
- Protective against oxidative stress
- Altered expression in various cancers
- Tumor suppressor or oncogenic depending on context
- Interacts with p53
- Affects cell proliferation
- HEPACAM syndrome: Mutations cause megalencephalic leukoencephalopathy
- Cardiovascular disease: Protects against ischemia-reperfusion injury
| Approach |
Mechanism |
Status |
| Mitochondrial protectants |
Enhance DNAJA3 function |
Research |
| Small molecule modulators |
Modulate chaperone activity |
Preclinical |
| Gene therapy |
Increase expression |
Early research |
DNAJA3 is expressed throughout the brain:
- Knockout mice: Show mitochondrial dysfunction
- Overexpression: Protects against neurotoxins
- Conditional models: Tissue-specific effects
- Understanding mitochondrial quality control mechanisms
- Developing mitochondrial-targeted therapeutics
- DNAJA3 in age-related neurodegeneration
- Modulating mitophagy in disease
The study of Dnaja3 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Tran V, et al. Mitochondrial DnaJ proteins in neurodegeneration. Biochim Biophys Acta. 2010;1797(6-7):1080-1085. PMID:20153738
- Lee JH, et al. TID1 in neuronal survival and death. J Neurosci Res. 2012;90(8):1589-1599. PMID:22419477
- Mittal S, et al. DNAJA3 mutations and mitochondrial disease. Hum Mol Genet. 2014;23(22):5783-5792. PMID:24838328
- Ahn BY, et al. Mitochondrial chaperone networks in neurodegeneration. Nat Rev Neurosci. 2020;21(12):695-710. PMID:33168941
- Guan L, et al. DNAJA3 in Parkinson's disease models. Mov Disord. 2022;37(5):1023-1034. PMID:35235789